Free Trial

Portage Biotech (PRTG) Short Interest Ratio & Short Volume

Portage Biotech logo

Portage Biotech Short Interest Data

Portage Biotech (PRTG) has a short interest of 36,200 shares, representing 4.28% of the float (the number of shares available for trading by the public). This marks a -3.21% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 56,380 shares to cover all short positions.

Current Short Interest
36,200 shares
Previous Short Interest
37,400 shares
Change Vs. Previous Month
-3.21%
Dollar Volume Sold Short
$314.22 thousand
Short Interest Ratio
0.4 Days to Cover
Last Record Date
August 15, 2025
Outstanding Shares
1,050,000 shares
Float Size
845,000 shares
Short Percent of Float
4.28%
Today's Trading Volume
377,941 shares
Average Trading Volume
56,380 shares
Today's Volume Vs. Average
670%
Short Selling Portage Biotech?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Portage Biotech and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

PRTG Short Interest Over Time

PRTG Days to Cover Over Time

PRTG Percentage of Float Shorted Over Time

Portage Biotech Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/15/202536,200 shares $314.22 thousand -3.2%4.3%0.4 $8.68
7/31/202537,400 shares $222.90 thousand -26.7%4.4%0.4 $5.96
7/15/202551,000 shares $291.72 thousand -45.6%9.1%0.2 $5.72
6/30/202593,700 shares $517.22 thousand +964.8%16.8%0.1 $5.52
6/15/20258,800 shares $52.71 thousand -45.7%3.2%0 $5.99
5/31/202516,200 shares $127.49 thousand -67.3%5.9%0 $7.87
5/15/202549,600 shares $374.48 thousand -56.6%30.3%0 $7.55
4/30/2025114,400 shares $1.36 million -13.3%70.0%0.1 $11.85
4/15/2025131,900 shares $1.05 million -57.2%80.7%0.1 $7.99
3/31/2025308,400 shares $2.85 million +2,134.8%50.7%0.5 $9.25
3/15/202513,800 shares $58.10 thousand -20.7%8.4%0.2 $4.21
2/28/202517,400 shares $78.47 thousand +33.9%10.6%0 $4.51
2/15/202513,000 shares $59.93 thousand -43.0%8.0%0 $4.61
1/31/202522,800 shares $100.55 thousand +15.2%5.2%0 $4.41
1/15/202519,800 shares $78.61 thousand -25.0%4.5%0 $3.97
12/31/202426,400 shares $136.49 thousand +175.0%6.0%0 $5.17
12/15/20249,600 shares $28.80 thousand +2.1%2.2%0 $3.00
11/30/20249,400 shares $39.34 thousand -6.9%2.2%0 $4.19
11/15/202410,100 shares $41.31 thousand -30.3%2.4%0 $4.09
10/31/202414,500 shares $82.36 thousand -22.9%3.4%0 $5.68
10/15/202418,800 shares $117.69 thousand +6.8%4.4%0 $6.26
9/30/202417,600 shares $117.04 thousand +87.2%4.2%0 $6.65
9/15/20249,400 shares $33.46 thousand -80.2%2.2%0 $3.56
8/31/202447,400 shares $163.53 thousand +558.3%11.2%0.1 $3.45
8/15/20247,200 shares $25.20 thousand -88.1%0.1%0 $3.50
7/31/202460,600 shares $10.67 thousand -75.0%0.7%0.1 $0.18
7/15/2024242,000 shares $43.56 thousand +1,628.6%2.8%0.3 $0.18
6/30/202414,000 shares $2.97 thousand -74.5%0.2%0 $0.21
6/15/202454,900 shares $13.73 thousand -9.3%0.6%0.2 $0.25
5/31/202460,500 shares $28.97 thousand +2.2%0.7%0.2 $0.48
5/15/202459,200 shares $15.13 thousand +2,473.9%0.7%0.3 $0.26
4/30/20242,300 shares $559.13 -72.6%0.0%0 $0.24
4/15/20248,400 shares $2.86 thousand +29.2%0.1%0.1 $0.34
3/31/20246,500 shares $3.66 thousand -57.8%0.1%0.1 $0.56
3/15/202415,400 shares $8.47 thousand -84.6%0.2%0.2 $0.55
2/29/2024100,200 shares $59.12 thousand +902.0%1.2%1.8 $0.59
2/15/202410,000 shares $6.01 thousand -9.1%0.1%0.2 $0.60
1/31/202411,000 shares $9.57 thousand +44.7%0.1%0.3 $0.87
1/15/20247,600 shares $8.21 thousand +16.9%0.1%0.2 $1.08
12/31/20236,500 shares $11.83 thousand -63.1%0.1%0.2 $1.82
12/15/202317,600 shares $22.35 thousand -25.4%0.2%0.5 $1.27
11/30/202323,600 shares $31.03 thousand -56.4%0.3%0.8 $1.32
11/15/202354,100 shares $78.45 thousand +4.4%0.7%2 $1.45
10/31/202351,800 shares $102.82 thousand -8.3%0.6%2.3 $1.99
10/15/202356,500 shares $119.78 thousand +4.2%0.7%2.5 $2.12
9/30/202354,200 shares $113.28 thousand +32.2%0.7%2.9 $2.09
9/15/202341,000 shares $118.49 thousand +494.2%0.5%2.9 $2.89
8/31/20236,900 shares $17.66 thousand -27.4%0.1%0.5 $2.56
8/15/20239,500 shares $22.80 thousand +30.1%0.1%0.7 $2.40
7/31/20237,300 shares $23.51 thousand +1.4%0.1%0.5 $3.22
7/15/20237,200 shares $24.41 thousand +22.0%0.1%0.5 $3.39
6/30/20235,900 shares $20.59 thousand -24.4%0.1%0.4 $3.49
6/15/20237,800 shares $28.86 thousand -1.3%0.1%0.4 $3.70
5/31/20237,900 shares $27.49 thousand -75.8%0.1%0.3 $3.48
5/15/202332,600 shares $104.65 thousand -10.4%0.4%1.3 $3.21
4/30/202336,400 shares $121.58 thousand -34.8%0.5%1.3 $3.34
4/15/202355,800 shares $175.77 thousand +5.5%0.7%1.7 $3.15
3/31/202352,900 shares $163.46 thousand +32.6%0.7%1.5 $3.09
3/15/202339,900 shares $119.70 thousand -6.8%0.5%1.1 $3.00
2/28/202342,800 shares $163.50 thousand -9.1%0.5%1.1 $3.82
2/15/202347,100 shares $198.76 thousand -3.1%0.4%1.3 $4.22
1/31/202348,600 shares $250.29 thousand +7.5%0.4%1.4 $5.15
1/15/202345,200 shares $246.15 thousand -11.2%0.3%1.7 $5.45
12/30/202250,900 shares $269.26 thousand +7.4%0.4%2.1 $5.29
12/15/202247,400 shares $237 thousand -0.8%0.4%2.3 $5.00
11/30/202247,800 shares $281.06 thousand +2.6%0.4%2.6 $5.88
11/15/202246,600 shares $280.07 thousand +2.4%0.4%3.2 $6.01
10/31/202245,500 shares $298.94 thousand -23.1%0.3%3.2 $6.57
10/15/202259,200 shares $400.19 thousand +11.1%0.9%3.9 $6.76
9/30/202253,300 shares $363.51 thousand +1.0%0.8%3.3 $6.82
9/15/202252,800 shares $414.48 thousand -23.6%0.8%2 $7.85
8/31/202269,100 shares $532.76 thousand +0.4%1.4%2.3 $7.71
8/15/202268,800 shares $580.67 thousand -12.1%1.4%1.9 $8.44
7/31/202278,300 shares $792.40 thousand +9.2%1.5%1.8 $10.12
7/15/202271,700 shares $646.02 thousand -6.0%1.4%1.6 $9.01
6/30/202276,300 shares $532.57 thousand -56.2%1.5%1.7 $6.98
6/15/2022174,100 shares $1.55 million -11.4%3.4%3.9 $8.93
5/31/2022196,500 shares $1.97 million -20.7%3.9%5.4 $10.00
5/15/2022247,900 shares $1.54 million +6.3%4.9%6.8 $6.20
4/30/2022233,200 shares $1.29 million +13.6%4.6%8.2 $5.54
4/15/2022205,300 shares $1.31 million +3.5%4.0%7.7 $6.39
3/31/2022198,400 shares $1.30 million +5.4%3.9%8.1 $6.57
3/15/2022188,200 shares $1.41 million +3.9%3.7%8.1 $7.51
2/28/2022181,100 shares $1.44 million +11.5%3.6%7.8 $7.95
2/15/2022162,400 shares $1.44 million +9.5%3.2%6.7 $8.84
1/31/2022148,300 shares $1.29 million +1.4%2.9%6 $8.68
1/15/2022146,200 shares $1.54 million +2.2%2.9%5.6 $10.54
12/31/2021143,100 shares $1.54 million +12.8%2.9%5.7 $10.73
12/15/2021126,900 shares $1.54 million +3.9%2.6%5.2 $12.13
11/30/2021122,200 shares $1.80 million -9.3%2.5%4.5 $14.73
11/15/2021134,700 shares $2.94 million -9.5%2.8%5.6 $21.86
10/29/2021148,800 shares $3.04 million +3.1%3.0%6.1 $20.40
10/15/2021144,400 shares $3.00 million -8.5%3.0%5.4 $20.79
9/30/2021157,800 shares $3.21 million +0.9%3.2%4.8 $20.32
9/15/2021156,400 shares $2.97 million -10.1%3.2%2.2 $18.97
8/31/2021174,000 shares $3.53 million -0.7%3.6%2.4 $20.31
8/13/2021175,200 shares $3.03 million No Change3.6%2.4 $17.32

PRTG Short Interest - Frequently Asked Questions

What is Portage Biotech's current short interest?

Short interest is the volume of Portage Biotech shares that have been sold short but have not yet been closed out or covered. As of August 15th, investors have sold 36,200 shares of PRTG short. 4.28% of Portage Biotech's shares are currently sold short. Learn More on Portage Biotech's current short interest.

What is a good short interest percentage for Portage Biotech?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.28% of Portage Biotech's floating shares are currently sold short.

Is Portage Biotech's short interest increasing or decreasing?

Portage Biotech saw a decrease in short interest in August. As of August 15th, there was short interest totaling 36,200 shares, a decrease of 3.2% from the previous total of 37,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Portage Biotech's float size?

Portage Biotech currently has issued a total of 1,050,000 shares. Some of Portage Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Portage Biotech currently has a public float of 845,000 shares.

How does Portage Biotech's short interest compare to its competitors?

4.28% of Portage Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Portage Biotech: Iterum Therapeutics PLC (3.59%), CASI Pharmaceuticals Inc. (8.18%), Kezar Life Sciences, Inc. (11.77%), Promis Neurosciences (0.43%), Dare Bioscience, Inc. (1.97%), Tenax Therapeutics, Inc. (7.90%), Clearside Biomedical, Inc. (2.29%), BioAtla, Inc. (7.56%), MIRA Pharmaceuticals, Inc. (1.84%), FibroBiologics Inc. (3.67%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Lucid Group, Inc. ($8.00 billion), Spotify Technology ($5.48 billion), AppLovin Corporation ($5.11 billion), Reddit Inc. ($5.02 billion), Coinbase Global, Inc. ($3.99 billion), Charter Communications, Inc. ($3.89 billion), Live Nation Entertainment, Inc. ($3.18 billion), Seagate Technology Holdings PLC ($2.59 billion), ResMed Inc. ($2.55 billion), and Rocket Lab Corporation ($2.52 billion). View all of the most shorted stocks.

What does it mean to sell short Portage Biotech stock?

Short selling PRTG is an investing strategy that aims to generate trading profit from Portage Biotech as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Portage Biotech?

A short squeeze for Portage Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PRTG, which in turn drives the price of the stock up even further.

How often is Portage Biotech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PRTG, twice per month. The most recent reporting period available is August, 15 2025.




This page (NASDAQ:PRTG) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners